Allergy Protection by Active IgE B Cell Vaccines

Chen, Swey-Shen

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Allergy and Infectious Diseases (NIAID)
• Type: Small Business Innovation Research Grants (SBIR) - Phase I (R43)
• Project #: 5R43AI054075-02
• Application #: 6693007
• Study Section: Special Emphasis Panel (ZRG1-SSS-4 (10))
• Program Officer: Prograis, Lawrence J
• Project Start: 2003-01-01
• Project End: 2004-12-31
• Budget Start: 2004-01-01
• Budget End: 2004-12-31
• Support Year: 2
• Fiscal Year: 2004
• Total Cost: $299,854

Institution

• Name: Ige Therapeutics, Inc.
• DUNS #: 094653941
• City: San Diego
• State: CA
• Country: United States
• Zip Code: 92121

Publications

Gong, Jian; Yang, Ning-Sun; Croft, Michael et al. (2010) The antigen presentation function of bone marrow-derived mast cells is spatiotemporally restricted to a subset expressing high levels of cell surface FcepsilonRI and MHC II. BMC Immunol 11:34

Chen, Swey-Shen; Barankiewicz, Teresa J; Yang, Yong-Min et al. (2008) IgE peptide-specific CTL inhibit IgE production: a transient IgE suppression model in wild-type and HLA-A2.1 transgenic mice. Cell Immunol 254:28-38

Yang, Yong-Min; Barankiewicz, Teresa J; He, Mingyue et al. (2007) Selection of antigenic markers on a GFP-Ckappa fusion scaffold with high sensitivity by eukaryotic ribosome display. Biochem Biophys Res Commun 359:251-7